Loss of CD44 and SOX2 Expression is Correlated with a Poor Prognosis in Esophageal Adenocarcinoma Patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of CD44 and SOX2 Expression is Correlated with a Poor Prognosis in Esophageal Adenocarcinoma Patients
Authors
Keywords
Overall Survival, Cancer Stem Cell, Esophageal Carcinoma, SOX2 Expression, Poor Overall Survival
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 21, Issue S4, Pages 657-664
Publisher
Springer Nature
Online
2014-05-16
DOI
10.1245/s10434-014-3763-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas
- (2014) Hideo Watanabe et al. JOURNAL OF CLINICAL INVESTIGATION
- Sox2 Cooperates with Inflammation-Mediated Stat3 Activation in the Malignant Transformation of Foregut Basal Progenitor Cells
- (2013) Kuancan Liu et al. Cell Stem Cell
- Increased SOX2 expression in less differentiated breast carcinomas and their lymph node metastases
- (2013) Yu-Hua Huang et al. HISTOPATHOLOGY
- Oesophageal carcinoma
- (2013) Arjun Pennathur et al. LANCET
- Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling
- (2013) J Zeilstra et al. ONCOGENE
- Autophagy and Cellular Senescence Mediated by Sox2 Suppress Malignancy of Cancer Cells
- (2013) Yong-Yeon Cho et al. PLoS One
- High SOX2 Levels Predict Better Outcome in Non-Small Cell Lung Carcinomas
- (2013) Vamsidhar Velcheti et al. PLoS One
- The Prognostic Value of SOX2 Expression in Non-Small Cell Lung Cancer: A Meta-Analysis
- (2013) Yansu Chen et al. PLoS One
- Regulation of human hematopoietic stem cell self-renewal by the microenvironment's control of retinoic acid signaling
- (2013) G. Ghiaur et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prediction of response to radiotherapy in the treatment of esophageal cancer using stem cell markers
- (2013) Justin K. Smit et al. RADIOTHERAPY AND ONCOLOGY
- SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells
- (2013) M Herreros-Villanueva et al. Oncogenesis
- Aldehyde Dehydrogenase 1 Expression is Associated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma
- (2012) Takuya Minato et al. ANNALS OF SURGICAL ONCOLOGY
- The oncoprotein and stem cell renewal factor BMI1 associates with poor clinical outcome in oesophageal cancer patients undergoing preoperative chemoradiotherapy
- (2012) Reigetsu Yoshikawa et al. BMC CANCER
- Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma
- (2012) Bonnie Choy et al. BMC GASTROENTEROLOGY
- Immunohistochemical panel for distinguishing esophageal adenocarcinoma from squamous cell carcinoma: a combination of p63, cytokeratin 5/6, MUC5AC, and anterior gradient homolog 2 allows optimal subtyping
- (2012) Michael A. DiMaio et al. HUMAN PATHOLOGY
- Sex-determining region Y-box 2 expression predicts poor prognosis in human ovarian carcinoma
- (2012) Jing Zhang et al. HUMAN PATHOLOGY
- Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
- (2012) P. van Hagen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Methylation of Cancer-Stem-Cell-Associated Wnt Target Genes Predicts Poor Prognosis in Colorectal Cancer Patients
- (2011) Felipe de Sousa E Melo et al. Cell Stem Cell
- SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer
- (2011) Theresia Wilbertz et al. MODERN PATHOLOGY
- A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable
- (2011) Hua Tian et al. NATURE
- The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations
- (2011) K. S. Yan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer
- (2010) S. Y. Park et al. CLINICAL CANCER RESEARCH
- Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
- (2010) Louis Vermeulen et al. NATURE CELL BIOLOGY
- Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers
- (2010) Shan Deng et al. PLoS One
- Cancer stem cells from colorectal cancer-derived cell lines
- (2010) Trevor M. Yeung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reduced Axin Protein Expression Is Associated with a Poor Prognosis in Patients with Squamous Cell Carcinoma of Esophagus
- (2009) Anna Fen-Yau Li et al. ANNALS OF SURGICAL ONCOLOGY
- Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy
- (2009) Susumu Saigusa et al. ANNALS OF SURGICAL ONCOLOGY
- SOX2 is highly expressed in squamous cell carcinomas of the gastrointestinal tract
- (2009) Kevin B. Long et al. HUMAN PATHOLOGY
- SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
- (2009) Adam J Bass et al. NATURE GENETICS
- Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44
- (2009) Shigeo Takaishi et al. STEM CELLS
- Altered expression of CD44 and DKK1 in the progression of Barrett’s esophagus to esophageal adenocarcinoma
- (2009) T. Darlavoix et al. VIRCHOWS ARCHIV
- SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis
- (2008) T Otsubo et al. BRITISH JOURNAL OF CANCER
- Crypt stem cells as the cells-of-origin of intestinal cancer
- (2008) Nick Barker et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started